New patent for the drug Slayback Pharma TESTOSTERONE CYPIONATE – DrugPatentWatch
Expired Annual Drug Patent for TESTOSTERONE+CYPIONATE
Testosterone Cypionate is a drug marketed by Am Regent, Cipla, Hikma, Hikma Farmaceutica, Padagis Us, Rising, Sandoz Inc, Sun Pharm Inds Ltd, Watson Labs, Watson Pharms Inc, Wilshire Pharms Inc, and Slayback Pharma Llc and, and is included in fourteen NDAs. It is available from thirteen suppliers. There is one patent protecting this drug.
The generic ingredient in TESTOSTERONE CYPIONATE is estradiol cypionate; testosterone cypionate. Thirteen registered suppliers for this complex. Additional details are available on estradiol cypionate; testosterone cypionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New Patent for the drug Slayback Pharma TESTOSTERONE CYPIONATE